PubMed İndeksli Yayınlar Koleksiyonu by Institution Author "Demirbaş, Hayri"
Now showing items 1-4 of 4
-
Acute cerebellitis, transverse myelitis and polyradiculoneuritis related to post-COVID-19 infection
Börü, Ülkü Türk; Bölük, Cem; Köseoğlu Toksoy, Cansu; Demirbaş, Hayri (Taylor & Francis Group, 29.09.2022)Context: Guillain-Barré syndrome (GBS), acute cerebellitis and transverse myelitis are rare complications of COVID-19 infection separately. The combination of these three, however, has not yet been reported. Findings: ... -
A case of Guillain-Barré syndrome related to COVID-19 infection
Börü, Ülkü Türk; Köseoğlu Toksoy, Cansu; Bölük, Cem; Demirbaş, Hayri; Yılmaz, Ahmet Çağdaş (Taylor and Francis Ltd., 2021)Background: After the first COVID-19 case, reported neurological complications are increasing day by day. Method: In this paper, we present a benign-course Guillain-Barré syndrome (GBS) emerging 2 weeks after COVID-19 ... -
Evaluation of cardiovascular autonomic dysfunction according to heart rate turbulence and variability in patients with relapsing remitting multiple sclerosis
Background/aim: Multiple sclerosis (MS) is an autoimmune disease characterized by neurodegeneration or demyelination; the relapsing–remitting phase of MS is characterized by acute exacerbation of disease activity. The most ... -
Natural products/bioactive compounds as a source of anticancer drugs
Tasmia Asma, Syeda; Acaroz, Ulaş; Imre, Kalman; Morar, Adriana; Şah, Seyyid Rızvan Ali; Hüseyin, Seyid Zajiv; Arslan Acaroz, Damla; Demirbaş, Hayri; Hayrulai Musliu, Zehra; İstanbullugil, Fatih Ramazan; Soleimanzadeh, Ali; Morozov, Dmitry; Zhu, Kui; Herman, Viorel; Ayad, Abdelhanine; Athanassiou, Christos; İnce, Sinan (Switzerland, 2022)Cancer is one of the major deadly diseases globally. The alarming rise in the mortality rate due to this disease attracks attention towards discovering potent anticancer agents to overcome its mortality rate. The discovery ...
